Powder: -20°C for 3 years | In solvent: -80°C for 1 year
3-Methyladipic acid is a metabolite of the catabolism of phytanic acid. Patients with adult Refsums disease (ARD) are unable to detoxify phytanic acid by alpha-oxidation, and so the w-oxidation pathway is the only metabolic pathway available for phytanic acid degradation. This pathway produces 3-methyladipic acid as the final metabolite, which is excreted in the urine.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 41.00 | |
1 g | In stock | $ 48.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | 3-Methyladipic acid is a metabolite of the catabolism of phytanic acid. Patients with adult Refsums disease (ARD) are unable to detoxify phytanic acid by alpha-oxidation, and so the w-oxidation pathway is the only metabolic pathway available for phytanic acid degradation. This pathway produces 3-methyladipic acid as the final metabolite, which is excreted in the urine. |
Molecular Weight | 160.17 |
Formula | C7H12O4 |
CAS No. | 3058-01-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
3-Methyladipic acid 3058-01-3 Metabolism Others Endogenous Metabolite 3Methyladipic acid inhibit Inhibitor 3 Methyladipic acid inhibitor